Dragan Grabulovski, Araris Biotech CEO

Ot­suka's Tai­ho buys Swiss start­up Araris with three AD­Cs near­ing the clin­ic

A small Swiss drug de­vel­op­er is be­ing scooped up for its pipeline of three an­ti­body-drug con­ju­gates that of­fer a next-gen­er­a­tion ap­proach to the area of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.